Skip to main content

Advertisement

Log in

Reduction of intercellular adhesion molecule 1 may play a role in anti-inflammatory effect of hyaluronic acid in a rat model of severe non-bacterial cystitis

  • Original Article
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Purpose

To evaluate the impact of intercellular adhesion molecule 1 (ICAM-1) in hyaluronic acid (HA) therapy in rats model of severe non-bacterial cystitis.

Methods

Cystitis models in Sprague–Dawley female rats were produced by combination of intraperitoneal cyclophosphamide (CYP) with intravesical protamine/lipopolysaccharide (PS/LPS). HA or heparin (0.5 ml) was introduced intravesically to rats’ bladders followed PS/LPS. Bladder tissue was prepared for histology including mast cell presence and measurement of ICAM-1, tumor necrosis factor (TNF)-α, and interleukin 6 (IL-6).

Results

Cystitis model using intraperitoneal CYP and intravesical SP/LPS showed serious inflammation, higher mast cell count with elevated ICAM-1, TNF-α, and IL-6 levels. After intravesical heparin or HA treatment, incidence of grades 3–4 bladder inflammation and tissue ICAM-1 level were only significantly lower in HA group (P = 0.017, P = 0.021, respectively), but not in heparin group (P = 0.12, P = 0.798, respectively). Remarkably lower level of TNF-α (P = 0.003) and ICAM-1 (P = 0.006) was detected in HA-treated rats compared with heparin-treated rats. Inflammation grade and ICAM-1 level had strong correlation (P < 0.001). IL-6 level after HA or heparin instillation had no difference.

Conclusions

Intravesical administration of HA decreased the severity of bladder inflammation, mast cell presence, and levels of ICAM-1 and TNF-α in a rat model of severe non-bacterial cystitis; its effect was more obvious than that of heparin. Reduction of ICAM-1 may play a role in the anti-inflammatory effect of HA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Berry SH, Bogart LM, Pham C, Liu K, Nyberg L, Stoto M, Suttorp M, Clemens JQ (2010) Development, validation and testing of an epidemiological case definition of interstitial cystitis/painful bladder syndrome. J Urol 183:1848–1852

    Article  PubMed  Google Scholar 

  2. Moldwin RM, Sant GR (2002) Interstitial cystitis: a pathophysiology and treatment update. Clin Obstet Gynecol 45:259–272

    Article  PubMed  Google Scholar 

  3. Riedl CR, Engelhardt PF, Daha KL, Morakis N, Pflüger H (2008) Hyaluronan treatment of interstitial cystitis/painful bladder syndrome. Int Urogynecol J 19:717–721

    Article  Google Scholar 

  4. Ahmad I, Sarath KN, Meddings RN (2008) Sequential hydrodistention and intravesical instillation of hyaluronic acid under general anaesthesia for treatment of refractory interstitial cystitis: a pilot study. Int Urogynecol J 19:543–546

    Article  Google Scholar 

  5. Nickel JC, Egerdie B, Downey J, Singh R, Skehan A, Carr L, Irvine-Bird K (2009) A real-life multicentre clinical practice study to evaluate the efficacy and safety of intravesical chondroitin sulphate for the treatment of interstitial cystitis. BJU Int 103:56–60

    Article  PubMed  Google Scholar 

  6. Shao Y, Shen ZJ, Rui WB, Zhou WL (2010). Intravesical instillation of hyaluronic acid prolonged the effect of bladder hydrodistention in patients with severe interstitial cystitis. Urology 75:547–550 (author reply 551)

    Google Scholar 

  7. Cox PJ (1979) Cyclophosphamide cystitis—identification of acrolein as the causative agent. Biochem Pharmacol 28:2045–2049

    Article  PubMed  CAS  Google Scholar 

  8. Lanteri-Minet M, Bon K, de Pommery J, Michiels JF, Menétrey D (1995) Cyclophosphamide cystitis as a model of visceral pain in rats: model elaboration and spinal structures involved as revealed by the expression of c-Fos and Krox-24 proteins. Exp Brain Res 105:220–232

    Article  PubMed  CAS  Google Scholar 

  9. Jerde TJ, Bjorling DE, Steinberg H, Warner T, Saban R (2000) Determination of mouse bladder inflammatory response to E. coli lipopolysaccharide. Urol Res 28:269–273

    Article  PubMed  CAS  Google Scholar 

  10. Boucher W, Stern JM, Kotsinyan V, Kempuraj D, Papaliodis D, Cohen MS, Theoharides TC (2008) Intravesical nanocrystalline silver decreases experimental bladder inflammation. J Urol 179:1598–1602

    Article  PubMed  CAS  Google Scholar 

  11. Liu W, Evanoff DP, Chen X, Luo Y (2007) Urinary bladder epithelium antigen induces CD8+ T cell tolerance, activation, and autoimmune response. J Immunol 178:539–546

    PubMed  CAS  Google Scholar 

  12. Cook EB, Stahl JL, Miller ST, Gern JE, Sukow KA, Graziano FM, Barney NP (1998) Isolation of human conjunctival mast cells and epithelial cells: tumor necrosis factor from mast cells affects intercellular adhesion molecule 1 expression on epithelial cells. Invest Ophthalmol Vis Sci 39:336–343

    PubMed  CAS  Google Scholar 

  13. Liebert M, Wedemeyer G, Stein JA, Washington R Jr, Faerber G, Flint A, Grossman HB (1993) Evidence for urothelial cell activation in interstitial cystitis. J Urol 149:470–475

    PubMed  CAS  Google Scholar 

  14. Leppilahti M, Hellström P, Tammela TL (2002) Effect of diagnostic hydrodistension and four intravesical hyaluronic acid instillations on bladder ICAM-1 intensity and association of ICAM-1 intensity with clinical response in patients with interstitial cystitis. Urology 60:46–51

    Article  PubMed  Google Scholar 

  15. Bona K, Lantéri-Mineta M, Menétreya D, Berkley KJ (1997) Sex, time-of-day and estrous variations in behavioral and bladder histological consequences of cyclophosphamide-induced cystitis in rats. Pain 73:423–429

    Article  Google Scholar 

  16. Soler R, Bruschini H, Truzzi JC et al (2008) Urinary glycosaminoglycans excretion and the effect of dimethyl sulfoxide in an experimental model of non-bacterial cystitis. Int Braz J Urol 34:503–511

    Article  PubMed  Google Scholar 

  17. Smaldone MC, Vodovotz Y, Tyagi V, Barclay D, Philips BJ, Yoshimura N, Chancellor MB, Tyagi P (2009) Multiplex analysis of urinary cytokine levels in a rat model of cyclophosphamide-induced cystitis. Urology 73:421–426

    Article  PubMed  Google Scholar 

  18. Springer TA (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76:301–314

    Article  PubMed  CAS  Google Scholar 

  19. McCourt PA, Ek B, Forsberg N, Gustafson S (1994) Intercellular adhesion molecule-1 is a cell surface receptor for hyaluronan. J Biol Chem 269:30081–30084

    PubMed  CAS  Google Scholar 

  20. Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA (1986) Induction by IL-1 and interferon-γ tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 137:245–254

    PubMed  CAS  Google Scholar 

  21. Sato H, Takahashi T, Ide H (1988) Antioxidant activity of synovial fluid, hyaluronic acid and two sub-components of hyaluronic acid: synovial fluid scavenging affect is enhanced in rheumatoid arthritis patients. Arthr Rheum 31:63–71

    Article  CAS  Google Scholar 

  22. Balasz EA, Denlinger JL (1984) The role of hyaluronic acid in arthritis and its therapeutic use. In: Peyron JG (ed) Osteoarthritis. Current clinical and fundamental problems. Geigy, Basel, pp 165–168

    Google Scholar 

  23. Gustafson S, Björkman T, Forsberg N, Lind T, Wikström T, Lidholt K (1995) Accessible hyaluronan receptors identical to ICAM-1 in mouse mast-cell tumors. Glycoconj J 12:350–355

    Article  PubMed  CAS  Google Scholar 

  24. Green M, Filippou A, Sant G, Theoharides TC (2004) Expression of intercellular adhesion molecules in the bladder of patients with interstitial cystitis. Urology 63:688–693

    Article  PubMed  CAS  Google Scholar 

  25. Sant GR, Kempuraj D, Marchand JE, Theoharides TC (2007) The mast cell in interstitial cystitis: role in pathophysiology and pathogenesis. Urology 69:34–40

    Article  PubMed  Google Scholar 

  26. Larsen MS, Mortensen S, Nordling J, Horn T (2008) Quantifying mast cells in bladder pain syndrome by immunohistochemical analysis. BJU Int 102:204–207

    Article  PubMed  Google Scholar 

  27. Theoharides TC, Sant GR (1997) The mast cell as a neuroimmunoendocrine effector in interstitial cystitis. In: Sant GR (ed) Interstitial cystitis. Lippincott-Raven, Philadelphia, pp 101–108

    Google Scholar 

  28. Welker P, Grabbe J, Grützkau A, Henz BM (1998) Effects of nerve growth factor (NGF) and other fibroblast-derived growth factors on immature human mast cells (HMC-1). Immunology 94:310–317

    PubMed  CAS  Google Scholar 

  29. Boucher WS, Letourneau R, Huang M, Kempuraj D, Green M, Sant GR, Theoharides TC (2002) Intravesical sodium hyaluronate inhibits the rat urinary mast cell mediator increase triggered by acute immobilization stress. J Urol 167:380–384

    Article  PubMed  CAS  Google Scholar 

  30. Hauser PJ, Buethe DA, Califano J et al (2009) Restoring barrier function to acid damaged bladder by intravesical chondroitin sulfate. J Urol 182:2477–2482

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors express their great thanks to Dr. Yi-fen CUI and Dr. Feng-ying LI for their splendid work in pathological examination and cytokine measurement.

Conflict of interest

The authors declare that they have no conflict of interest or financial disclosure.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yuan Shao.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shao, Y., Lu, Gl., Shen, ZJ. et al. Reduction of intercellular adhesion molecule 1 may play a role in anti-inflammatory effect of hyaluronic acid in a rat model of severe non-bacterial cystitis. World J Urol 31, 535–540 (2013). https://doi.org/10.1007/s00345-012-0839-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-012-0839-8

Keywords

Navigation